AU7315001A - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Info

Publication number
AU7315001A
AU7315001A AU7315001A AU7315001A AU7315001A AU 7315001 A AU7315001 A AU 7315001A AU 7315001 A AU7315001 A AU 7315001A AU 7315001 A AU7315001 A AU 7315001A AU 7315001 A AU7315001 A AU 7315001A
Authority
AU
Australia
Prior art keywords
secreted
same
nucleic acids
acids encoding
transmembrane polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU7315001A
Inventor
P Baker Kevin
Desnoyers Luc
E Gerritsen Mary
Goddard Audrey
J Godowski Paul
Christopher Grimaldi J
L Gurney Austin
Smith Victoria
F Stephan Jean-Philippe
K Watanabe Colin
I Wood William
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/020710 external-priority patent/WO2001009327A2/en
Priority claimed from PCT/US2000/023522 external-priority patent/WO2001016319A2/en
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/030873 external-priority patent/WO2001040465A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Priority claimed from PCT/US2000/034956 external-priority patent/WO2001046420A2/en
Priority claimed from US09/747,259 external-priority patent/US6569645B2/en
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/en
Priority claimed from PCT/US2001/006666 external-priority patent/WO2001066740A2/en
Priority claimed from US09/816,744 external-priority patent/US6579520B2/en
Priority claimed from US09/854,208 external-priority patent/US7217412B2/en
Priority claimed from PCT/US2001/017092 external-priority patent/WO2001092331A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU7315001A publication Critical patent/AU7315001A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
AU7315001A 2000-07-20 2001-07-02 Secreted and transmembrane polypeptides and nucleic acids encoding the same Pending AU7315001A (en)

Applications Claiming Priority (26)

Application Number Priority Date Filing Date Title
US21955600P 2000-07-20 2000-07-20
US22066600P 2000-07-25 2000-07-25
US22062400P 2000-07-25 2000-07-25
US22058500P 2000-07-25 2000-07-25
US22060500P 2000-07-25 2000-07-25
US22066400P 2000-07-25 2000-07-25
US22063800P 2000-07-25 2000-07-25
US22060700P 2000-07-25 2000-07-25
US22089300P 2000-07-26 2000-07-26
PCT/US2000/020710 WO2001009327A2 (en) 1999-07-28 2000-07-28 Method of preventing the injury or death of retinal cells and treating ocular diseases
US22242500P 2000-08-01 2000-08-01
US22713300P 2000-08-22 2000-08-22
PCT/US2000/023522 WO2001016319A2 (en) 1999-08-31 2000-08-23 Compositions and methods for the treatment of immune related diseases
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/030873 WO2001040465A2 (en) 1999-11-30 2000-11-10 Compositions and methods for the treatment of immune related diseases
US25364600P 2000-11-28 2000-11-28
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/034956 WO2001046420A2 (en) 1999-12-23 2000-12-20 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
US09/747,259 US6569645B2 (en) 1999-05-14 2000-12-20 IL-17 homologous polypeptides and therapeutic uses thereof
PCT/US2001/006520 WO2001068848A2 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/006666 WO2001066740A2 (en) 2000-03-03 2001-03-01 Compositions and methods for the treatment of immune related diseases
US09/816,744 US6579520B2 (en) 1998-05-15 2001-03-22 IL-17 related mammalian cytokine polypeptides (IL-17E)
US09/854,208 US7217412B2 (en) 1998-05-15 2001-05-10 IL-17C related mammalian cytokine polypeptides
US09/854,280 US7115398B2 (en) 1998-05-15 2001-05-10 IL-17 homologous polypeptides and therapeutic uses thereof
PCT/US2001/017092 WO2001092331A2 (en) 2000-05-30 2001-05-25 Compositions and methods for the treatment of immune related diseases
PCT/US2001/021066 WO2002008288A2 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
AU7315001A true AU7315001A (en) 2002-01-30

Family

ID=56290161

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001273150A Abandoned AU2001273150A1 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7315001A Pending AU7315001A (en) 2000-07-20 2001-07-02 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001273150A Abandoned AU2001273150A1 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Country Status (5)

Country Link
EP (1) EP1354040A2 (en)
JP (1) JP2004514420A (en)
AU (2) AU2001273150A1 (en)
CA (1) CA2416456A1 (en)
WO (1) WO2002008288A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112955185A (en) * 2018-06-22 2021-06-11 医福斯治疗有限公司 Combination gene therapy

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012179A2 (en) 1997-09-12 2000-06-28 Apotech R&D S.A. Cysteine rich receptors: trail
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US20020106728A1 (en) * 2000-06-20 2002-08-08 Genentech, Inc. NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
DK1897944T3 (en) * 1999-12-23 2011-10-24 Genentech Inc IL-17 homologous polypeptides and their therapeutic use
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1666497A3 (en) * 2000-06-02 2006-06-21 Genentech, Inc. Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
US20030017572A1 (en) * 2000-09-25 2003-01-23 Rajasekhar Bandaru 56294 and 56629, novel human metalloproteases and uses thereof
US20050048483A1 (en) * 2000-09-28 2005-03-03 Su Eric Wen Novel secreted proteins and their uses
CA2427800A1 (en) 2000-11-03 2002-05-10 The Regents Of The University Of California Prokineticin polypeptides, related compositions and methods
CA2431861A1 (en) 2000-12-08 2002-06-13 Curagen Corporation Method of detecting and treating tuberous sclerosis complex associated disorders
DE10106835A1 (en) * 2001-02-14 2002-09-05 Basf Lynx Bioscience Ag Signal transduction proteins 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences
GB2378183A (en) * 2001-04-25 2003-02-05 Smithkline Beecham Corp Assays of the interaction between AXOR8 or AXOR52 and BV-8 ligand
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
CA2446610A1 (en) * 2001-06-06 2002-12-12 Human Genome Sciences, Inc. 20 human secreted proteins
EP1961811B1 (en) 2002-01-18 2010-08-25 ZymoGenetics, Inc. Cytokine ligand for the treatment of asthma and airway hyper-responsiveness
KR20040101502A (en) * 2002-04-16 2004-12-02 제넨테크, 인크. Compositions and Methods for the Diagnosis and Treatment of Tumor
US7141381B2 (en) 2002-04-25 2006-11-28 Bristol-Myers Squibb Company Human leucine-rich repeat-containing proteins specifically expressed in the nervous system
ES2318079T3 (en) 2002-10-31 2009-05-01 F. Hoffmann-La Roche Ag METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER AND UTI LES COMPOSITIONS IN THE SAME.
DE10254601A1 (en) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
EP1573048A4 (en) * 2002-12-20 2007-02-14 Avalon Pharmaceuticals Breast specific protein expressed in cancer and methods of use thereof
EP1615659B1 (en) 2003-03-12 2014-04-16 Genentech, Inc. Use of bv8 and/or eg-vegf to promote hematopoiesis
US7479479B2 (en) 2003-04-30 2009-01-20 Centocor, Inc. CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
EP1617802A4 (en) * 2003-04-30 2007-08-01 Centocor Inc Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses.
EP1503212B1 (en) * 2003-07-28 2007-05-23 F. Hoffmann-La Roche Ag Methods for diagnosis and therapy of metastasis and composition useful therein
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
JPWO2005083075A1 (en) * 2004-03-02 2007-11-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 Novel genes involved in epidermal differentiation and their use
PT1781682E (en) 2004-06-24 2013-05-14 Mayo Foundation B7-h5, a costimulatory polypeptide
AU2005270078A1 (en) 2004-07-02 2006-02-09 Genentech, Inc. Compositions and methods for treatment of non-hodgkin's lymphoma
US7846438B2 (en) 2004-08-03 2010-12-07 Biogen Idec Ma Inc. Methods of promoting neurite outgrowth with soluble TAJ polypeptides
US8101183B2 (en) 2005-05-06 2012-01-24 Zymogentics, Inc. Variable region sequences of IL-31 monoclonal antibodies
US20130216542A1 (en) 2005-05-06 2013-08-22 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
CN101198624B (en) 2005-05-06 2012-10-10 津莫吉尼蒂克斯公司 IL-31 monoclonal antibodies and methods of use
JP2007063225A (en) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd Imidazopyridine compound
EP1991581A2 (en) 2006-01-10 2008-11-19 Zymogenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
WO2007104034A2 (en) 2006-03-08 2007-09-13 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
EP2796466B1 (en) 2007-12-07 2017-11-22 ZymoGenetics, Inc. Humanized antibody molecules specific for IL-31
WO2009136286A2 (en) 2008-05-05 2009-11-12 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
LT2398902T (en) 2009-02-20 2023-12-27 Astellas Pharma Inc. Methods and compositions for diagnosis and treatment of cancer
WO2010128407A2 (en) 2009-05-05 2010-11-11 Novimmune S.A. Anti-il-17f antibodies and methods of use thereof
LT2499161T (en) 2009-11-11 2017-11-27 Ganymed Pharmaceuticals Gmbh Antibodies specific for claudin 6 (cldn6)
EP2404936A1 (en) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
LT3026064T (en) 2011-05-13 2019-01-25 Ganymed Pharmaceuticals Gmbh Antibodies for treatment of cancer expressing claudin 6
US9848543B2 (en) 2013-07-09 2017-12-26 E I Du Pont De Nemours And Company System and method for irrigation
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
CN111848792B (en) * 2020-07-16 2023-02-24 浙江省食品药品检验研究院 Preparation method and detection method of antibody of bovine serum albumin and other impurities in vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO2000053756A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6060249A (en) * 1997-02-27 2000-05-09 Genentech, Inc. Method of selection for genes encoding secreted and transmembrane proteins
AU3753499A (en) * 1998-04-20 1999-11-08 Paul B. Fisher Colon cancer-associated antigens and their diagnostic and therapeutic uses
JP2002538811A (en) * 1999-03-12 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 49 human secreted proteins
ATE449109T1 (en) * 1999-06-15 2009-12-15 Genentech Inc SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS FOR THE ENCODING THEM
WO2001059064A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112955185A (en) * 2018-06-22 2021-06-11 医福斯治疗有限公司 Combination gene therapy

Also Published As

Publication number Publication date
CA2416456A1 (en) 2002-01-31
EP1354040A2 (en) 2003-10-22
WO2002008288A3 (en) 2003-08-14
AU2001273150A1 (en) 2002-02-05
JP2004514420A (en) 2004-05-20
WO2002008288A2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU6802801A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7315001A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6531101A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1661002A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL139686A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL201001A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7573000A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2055401A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883700A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883900A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL141535A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1490386A4 (en) Novel polypeptides and nucleic acids encoding the same
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1173456A4 (en) Secreted proteins and nucleic acids encoding them
AU2001249394A1 (en) Secreted proteins and polynucleotides encoding them
AU2002367815A8 (en) Novel nucleic acids and secreted polypeptides
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
KR100514265B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100473125B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100528420B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100498658B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
AU4587101A (en) Novel human secreted proteins and polynucleotides encoding the same
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same
IL142673A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5152700A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same